Section Arrow
Quote
CNTB.NASDAQ
- Connect Biopharma Holdings Limited
(Financial Status)
Quotes are at least 15-min delayed:2025/05/31 19:54 EDT
Last
 0.84
+0.06 (+7.69%)
Day High 
0.84 
Prev. Close
0.78 
1-M High
0.86 
Volume 
57.44K 
Bid
0.8103
Ask
0.839
Day Low
0.7818 
Open
0.81 
1-M Low
0.7 
Market Cap 
43.34M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.78 
20-SMA 0.79 
50-SMA 0.75 
52-W High 2.0699 
52-W Low 0.51 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.31/-1.32
Enterprise Value
43.36M
Balance Sheet
Book Value Per Share
1.49
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
26.03M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
INABIN8bio0.1446-0.0088-5.74%-- 
BLRXBioLineRx Ltd5.18+1.3891+36.64%-- 
IMNNImunon2.45+0.46+23.12%-- 
NCNANuCana plc0.03525-0.00175-4.73%-- 
MRNAModerna26.58-0.35-1.30%-- 
Quotes are at least 15-min delayed：2025/05/31 19:54 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.